An observational study in Osteoporosis, Osteopenia, sponsored by Promedius Inc. Recruiting at 3 sites in 2 countries. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Promedius Inc · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Osteoporosis with a site in United Kingdom — 8 open to participants now, 9 under way, none of them phase 3. Osteoporosis · United Kingdom.
Among the 57 studies in Osteoporosis with a site in United Kingdom, this one is the 9th largest by planned enrollment of the 21 observational ones that give a count, is one of 2 that started in 2026, is one of 21 observational ones, and was the 57th registered.
1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.
Browse Osteoporosis studies →8 of the 57 studies in Osteoporosis with a site in United Kingdom are open now. Recruiting first, the newest first:
AO Foundation, AO Spine · Sites in United Kingdom, United States, Argentina and 11 more countries
Ages 50+
Bradford Institute for Health Research · Sites in United Kingdom
Ages 70+
King's College London · Sites in United Kingdom
Ages 18+
Relation Therapeutics · Sites in United Kingdom
Ages 18–110
AgNovos Healthcare, LLC · Sites in United Kingdom, Austria, Belgium and 8 more countries
Ages 65–91 · Women only
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.
This study: 50 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 11 · Phase 4 4
First in 1992; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 595 is above the median of 160 across 456 observational studies indexed under Osteoporosis.
Median enrollment 110 across the 35 interventional studies, 440 across the 21 observational. Of the 37 that completed or were terminated, 8 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 57 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Promedius Inc as lead sponsor.
Promedius Inc has 1 study filed under Osteoporosis — fewer than ten, so there is no comparison to draw.
3 of the studies in Osteoporosis with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07421713Promedius IncA Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older | 2026-11-30 |
| NCT05889598Loughborough UniversityResistance Exercise Training to Improve Bone and Articular Cartilage Health in Women | 2026-12-31 |
| NCT04796350AgNovos Healthcare, LLCRESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | 2027-04-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 57 studies in Osteoporosis with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to assess the performance of an artificial intelligence software (Osteo Signal) in detecting osteoporosis risk in adults 50 years and older. The main question it aims to answer is: What is the accuracy of the software in detecting osteoporosis risk on chest x-ray images as compared to the standard technique of dual-energy x-ray absorptiometry (DXA)? There is no direct involvement of participants in this study as it will use data from individuals who have already had a chest x-ray and a DXA scan taken in the past.
Patients selected hospitals in the Netherlands and UK that have previously had chest x-rays and DXA scans
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Availability of
Exclusion Criteria:
Non-diagnostic Quality or Incomplete Imaging of:
Previous diagnosis or treatment of Osteoporosis prior to the DXA scan used in the Study.
Major Chest Wall or Spinal Deformities, including but not limited to:
Artificial Intelligence (AI) software
Two class bone status classification (osteoporosis/non osteoporosis)
Device output against the lowest DXA as measured by sensitivity, specificity, and area under the ROC curve (AUC)
Time frame: At a time following the participant having had a chest x-ray and DXA scan within 6 months of each other
Three class bone status classification (osteoporosis/osteopenia/normal)
Device output against the lowest DXA as measured by area under the ROC curve (AUC), overall per cent agreement, and weighted Cohen's kappa
Time frame: At a time following the participant having had a chest x-ray and DXA scan within 6 months of each other
Classification for osteoporosis and osteopenia
Positive predictive value (PPV) and negative predictive value (NPV) for osteoporosis and osteopenia classifications
Time frame: At a time following the participant having had a chest x-ray and DXA scan within 6 months of each other
Plan to share: No — No IPD will be shared. The trial data is proprietary and part of a product development program.
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: primary completion Mar 2026 → Nov 2026 and completion Mar 2026 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.